1. Generics Bulletin
  2. >>Products

Apotex Moves First On Combigan As US Patent Expiry Looms

10 Orange Book Listed Patents Will Expire On 19 April

 
• By Dean Rudge

Apotex has moved first on Allergan’s Combigan, introducing a US authorized generic as the clock ticks on the originator’s IP. Sandoz is among ANDA sponsors seemingly waiting for patent protection to lapse.

Chess
Apotex' authorized generic will compete with the brand • Source: Alamy

Apotex Inc. has announced the launch of a first-to-market authorized generic version of AbbVie’s Combigan (brimonidine tartrate/timolol maleate) 0.2%/0.5% ophthalmic solution in the US.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Products

More from Generics Bulletin